Pharma R&D Today

Finding Key Collaborators in the Data

Posted on August 23rd, 2017 by Christine de Vries - Scheidegger in Pharma R&D

R&D is no longer a solely in-house process where Big Pharma researchers work diligently in secret to come up with the next blockbuster drug. Rising costs, patient needs, global trends, healthcare reform, changes in clinical development models and many other factors have altered the R&D landscape. In today’s environment, pharmaceutical firms must reach outward in order to innovate. Continue reading “Finding Key Collaborators in the Data” »